Outcomes of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Followed by High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDCT/ASCT) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

被引：0
|
作者：
Abdallah, Al-Ola [1 ]
Mohyuddin, Ghulam Rehman [1 ]
Mahmoudjafari, Zahra [2 ]
Shebli, Atrash [3 ]
Kawsar, Hameem [2 ]
Sigle, Monia [2 ]
Shune, Leyla [1 ]
McGuirk, Joseph [1 ]
Ganguly, Siddhartha [1 ]
机构：
[1] Univ Kansas, Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA
[2] Univ Kansas, Med Ctr, Westwood, KS USA
[3] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
daratumumab; pomalidomide; relapsed/refractory myeloma; MM;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-235
引用
收藏
页码：S303 / S303
页数：1
相关论文
共 50 条
  • [41] Impact of oral mucositis on outcomes of multiple myeloma patients treated with high-dose melphalan conditioning and autologous stem cell transplantation (ASCT).
    Jaguar, Graziella Chagas
    Rodrigues, Gustavo Henrique
    Guollo, Andre
    Camandoni, Vanessa Oliveira
    Magalhaes, Leila Maria
    Melo, Pessoa
    Alves, Fabio Abreu
    Cordeiro Lima, Vladmir Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA WITH RENAL FAILURE
    Pokrovskaya, O.
    Mendeleeva, L.
    Urnova, E.
    Firsova, M.
    Nareyko, M.
    Kuzmina, L.
    Rekhtina, I.
    Tauson, I.
    Varlamova, E.
    Parovichnikova, E.
    Savchenko, V.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S345 - S346
  • [43] Immune Profiling of Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide and Low-Dose Dexamethasone in Combination with Daratumumab
    Pierceall, William E.
    Bahlis, Nizar
    Siegel, David S.
    Schiller, Gary J.
    Samaras, Christy J.
    Sebag, Michael
    Berdeja, Jesus G.
    Ganguly, Siddhartha
    Matous, Jeffrey V.
    Song, Kevin
    Seet, Christopher S.
    Talamo, Giampaolo
    Srinivas, Shanti
    Acosta-Rivera, Mirelis
    Bar, Michael
    Quick, Donald P.
    Anz, Bertrand
    Fonseca, Gustavo
    Reece, Donna
    Chung, Weiyuan
    Serbina, Natalya
    Zafar, Faiza
    Agarwal, Amit
    Thakurta, Anjan
    BLOOD, 2018, 132
  • [44] Pomalidomide (POM) with Low-Dose Dexamethasone (LoDEX) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Impact of Renal Function on Patient Outcomes
    Siegel, David S.
    Richardson, Paul G.
    Baz, Rachid
    Chen, Min
    Zaki, Mohamed
    Anderson, Kenneth C.
    BLOOD, 2012, 120 (21)
  • [45] High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma
    Park, Kwonoh
    Yoon, Dok Hyun
    Kim, Shin
    Park, Chan-Sik
    Huh, Jooryung
    Lee, Sang-Wook
    Suh, Cheolwon
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) : 256 - 262
  • [46] High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma
    Kwonoh Park
    Dok Hyun Yoon
    Shin Kim
    Chan-Sik Park
    Jooryung Huh
    Sang-Wook Lee
    Cheolwon Suh
    International Journal of Hematology, 2013, 97 : 256 - 262
  • [47] High-dose chemotherapy and autologous stem cell transplantation for Korean patients with relapsed or refractory Hodgkin's lymphoma
    Park, K.
    Yoon, D.
    Kim, S.
    Huh, J.
    Park, C.
    Lee, S.
    Park, S.
    Ahn, Y.
    Jo, J.
    Suh, C.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S445 - S445
  • [48] High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma
    Sauerbrey, A
    Bielack, S
    Kempf-Bielack, B
    Zoubek, A
    Paulussen, M
    Zintl, F
    BONE MARROW TRANSPLANTATION, 2001, 27 (09) : 933 - 937
  • [49] Treatment outcomes in multiple sclerosis (MS) patients after early, conventional and salvage high dose chemotherapy (HDCT) plus autologous stem cell transplantation (ASCT).
    Shevchenko, YL
    Novik, AA
    Afanasiev, BV
    Lisukov, IA
    Ionova, TI
    Kulagin, AD
    Malysheva, OA
    Bisaga, GN
    Melnichenko, VJ
    Voloshin, SV
    Fedorenko, DA
    Vereschagina, IV
    Kishtovich, AV
    Fedotov, YN
    Gorodokin, GI
    BLOOD, 2005, 106 (11) : 454B - 454B
  • [50] High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma
    A Sauerbrey
    S Bielack
    B Kempf-Bielack
    A Zoubek
    M Paulussen
    F Zintl
    Bone Marrow Transplantation, 2001, 27 : 933 - 937
12345